HIV co-infection increases the risk of post-tuberculosis mortality among patients treated for drug resistant tuberculosis.
Argita D SalindriMaia KipianiNino LomtadzeNestani TukvadzeZaza AvalianiHenry M BlumbergKatherine E MasynRichard B RothenbergRussell R KempkerMatthew J MageePublished in: medRxiv : the preprint server for health sciences (2023)
Our findings provide evidence that TB patients with comorbidities, especially HIV, may have a significantly increased risk of post-TB mortality compared to those without comorbidities. We also found that most post-TB mortality occurred within three years after TB treatment completion.
Keyphrases
- mycobacterium tuberculosis
- drug resistant
- hiv aids
- antiretroviral therapy
- cardiovascular events
- hiv positive
- hiv infected
- human immunodeficiency virus
- multidrug resistant
- hiv testing
- hepatitis c virus
- pulmonary tuberculosis
- acinetobacter baumannii
- men who have sex with men
- risk factors
- coronary artery disease
- type diabetes
- pseudomonas aeruginosa
- adverse drug
- cystic fibrosis
- smoking cessation